Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Injectable Implant Urinary Incontinence Device Market Research Report 2025

Global Injectable Implant Urinary Incontinence Device Market Research Report 2025

Industry: Medical Devices & Consumables

Published Date: 2025-01-16

Pages: 67 Pages

Report ld: 3444474

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Injectable Implant Urinary Incontinence Device Market Size(US$)

CAGR 2025-2031

5.9%

Market Size,2031

USD 185

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 131 million

Market Forecast in 2031(Value)

US$ 185 million

CAGR

5.9%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Injectable Implant Urinary Incontinence Device was valued at US$ 124 million in the year 2024 and is projected to reach a revised size of US$ 185 million by 2031, growing at a CAGR of 5.9% during the forecast period.

Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Injectable Implant Urinary Incontinence Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Implant Urinary Incontinence Device.

The Injectable Implant Urinary Incontinence Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Injectable Implant Urinary Incontinence Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Injectable Implant Urinary Incontinence Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Boston Scientific

Laborie Medical

Urogyn B.V.

Segment by Type

Stress Incontinence

Urge Incontinence

Overflow Incontinence

Functional Incontinence

Others

Segment by Application

Hospitals and Clinics

Ambulatory Surgery Centres

Others

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Injectable Implant Urinary Incontinence Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Injectable Implant Urinary Incontinence Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Injectable Implant Urinary Incontinence Device Market Overview

1.1 Product Definition

1.2 Injectable Implant Urinary Incontinence Device by Type

1.2.1 Global Injectable Implant Urinary Incontinence Device Market Value Comparison by Type (2024 VS 2031)

1.2.2 Stress Incontinence

1.2.3 Urge Incontinence

1.2.4 Overflow Incontinence

1.2.5 Functional Incontinence

1.2.6 Others

1.3 Injectable Implant Urinary Incontinence Device by Application

1.3.1 Global Injectable Implant Urinary Incontinence Device Market Value by Application (2024 VS 2031)

1.3.2 Hospitals and Clinics

1.3.3 Ambulatory Surgery Centres

1.3.4 Others

1.4 Global Injectable Implant Urinary Incontinence Device Market Size Estimates and Forecasts

1.4.1 Global Injectable Implant Urinary Incontinence Device Revenue 2020-2031

1.4.2 Global Injectable Implant Urinary Incontinence Device Sales 2020-2031

1.4.3 Global Injectable Implant Urinary Incontinence Device Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Injectable Implant Urinary Incontinence Device Market Competition by Manufacturers

2.1 Global Injectable Implant Urinary Incontinence Device Sales Market Share by Manufacturers (2020-2025)

2.2 Global Injectable Implant Urinary Incontinence Device Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Injectable Implant Urinary Incontinence Device Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Injectable Implant Urinary Incontinence Device, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Injectable Implant Urinary Incontinence Device, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Injectable Implant Urinary Incontinence Device, Product Type & Application

2.7 Global Key Manufacturers of Injectable Implant Urinary Incontinence Device, Date of Enter into This Industry

2.8 Global Injectable Implant Urinary Incontinence Device Market Competitive Situation and Trends

2.8.1 Global Injectable Implant Urinary Incontinence Device Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Injectable Implant Urinary Incontinence Device Players Market Share by Revenue

2.8.3 Global Injectable Implant Urinary Incontinence Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Injectable Implant Urinary Incontinence Device Market Scenario by Region

3.1 Global Injectable Implant Urinary Incontinence Device Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Injectable Implant Urinary Incontinence Device Sales by Region: 2020-2031

3.2.1 Global Injectable Implant Urinary Incontinence Device Sales by Region: 2020-2025

3.2.2 Global Injectable Implant Urinary Incontinence Device Sales by Region: 2026-2031

3.3 Global Injectable Implant Urinary Incontinence Device Revenue by Region: 2020-2031

3.3.1 Global Injectable Implant Urinary Incontinence Device Revenue by Region: 2020-2025

3.3.2 Global Injectable Implant Urinary Incontinence Device Revenue by Region: 2026-2031

3.4 North America Injectable Implant Urinary Incontinence Device Market Facts & Figures by Country

3.4.1 North America Injectable Implant Urinary Incontinence Device Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Injectable Implant Urinary Incontinence Device Sales by Country (2020-2031)

3.4.3 North America Injectable Implant Urinary Incontinence Device Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Injectable Implant Urinary Incontinence Device Market Facts & Figures by Country

3.5.1 Europe Injectable Implant Urinary Incontinence Device Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Injectable Implant Urinary Incontinence Device Sales by Country (2020-2031)

3.5.3 Europe Injectable Implant Urinary Incontinence Device Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Injectable Implant Urinary Incontinence Device Market Facts & Figures by Region

3.6.1 Asia Pacific Injectable Implant Urinary Incontinence Device Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Injectable Implant Urinary Incontinence Device Sales by Region (2020-2031)

3.6.3 Asia Pacific Injectable Implant Urinary Incontinence Device Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Injectable Implant Urinary Incontinence Device Market Facts & Figures by Country

3.7.1 Latin America Injectable Implant Urinary Incontinence Device Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Injectable Implant Urinary Incontinence Device Sales by Country (2020-2031)

3.7.3 Latin America Injectable Implant Urinary Incontinence Device Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Injectable Implant Urinary Incontinence Device Market Facts & Figures by Country

3.8.1 Middle East and Africa Injectable Implant Urinary Incontinence Device Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Injectable Implant Urinary Incontinence Device Sales by Country (2020-2031)

3.8.3 Middle East and Africa Injectable Implant Urinary Incontinence Device Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Injectable Implant Urinary Incontinence Device Sales by Type (2020-2031)

4.1.1 Global Injectable Implant Urinary Incontinence Device Sales by Type (2020-2025)

4.1.2 Global Injectable Implant Urinary Incontinence Device Sales by Type (2026-2031)

4.1.3 Global Injectable Implant Urinary Incontinence Device Sales Market Share by Type (2020-2031)

4.2 Global Injectable Implant Urinary Incontinence Device Revenue by Type (2020-2031)

4.2.1 Global Injectable Implant Urinary Incontinence Device Revenue by Type (2020-2025)

4.2.2 Global Injectable Implant Urinary Incontinence Device Revenue by Type (2026-2031)

4.2.3 Global Injectable Implant Urinary Incontinence Device Revenue Market Share by Type (2020-2031)

4.3 Global Injectable Implant Urinary Incontinence Device Price by Type (2020-2031)

5 Segment by Application

5.1 Global Injectable Implant Urinary Incontinence Device Sales by Application (2020-2031)

5.1.1 Global Injectable Implant Urinary Incontinence Device Sales by Application (2020-2025)

5.1.2 Global Injectable Implant Urinary Incontinence Device Sales by Application (2026-2031)

5.1.3 Global Injectable Implant Urinary Incontinence Device Sales Market Share by Application (2020-2031)

5.2 Global Injectable Implant Urinary Incontinence Device Revenue by Application (2020-2031)

5.2.1 Global Injectable Implant Urinary Incontinence Device Revenue by Application (2020-2025)

5.2.2 Global Injectable Implant Urinary Incontinence Device Revenue by Application (2026-2031)

5.2.3 Global Injectable Implant Urinary Incontinence Device Revenue Market Share by Application (2020-2031)

5.3 Global Injectable Implant Urinary Incontinence Device Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Boston Scientific

6.1.1 Boston Scientific Company Information

6.1.2 Boston Scientific Description and Business Overview

6.1.3 Boston Scientific Injectable Implant Urinary Incontinence Device Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Boston Scientific Injectable Implant Urinary Incontinence Device Product Portfolio

6.1.5 Boston Scientific Recent Developments/Updates

6.2 Laborie Medical

6.2.1 Laborie Medical Company Information

6.2.2 Laborie Medical Description and Business Overview

6.2.3 Laborie Medical Injectable Implant Urinary Incontinence Device Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Laborie Medical Injectable Implant Urinary Incontinence Device Product Portfolio

6.2.5 Laborie Medical Recent Developments/Updates

6.3 Urogyn B.V.

6.3.1 Urogyn B.V. Company Information

6.3.2 Urogyn B.V. Description and Business Overview

6.3.3 Urogyn B.V. Injectable Implant Urinary Incontinence Device Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Urogyn B.V. Injectable Implant Urinary Incontinence Device Product Portfolio

6.3.5 Urogyn B.V. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Injectable Implant Urinary Incontinence Device Industry Chain Analysis

7.2 Injectable Implant Urinary Incontinence Device Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Injectable Implant Urinary Incontinence Device Production Mode & Process Analysis

7.4 Injectable Implant Urinary Incontinence Device Sales and Marketing

7.4.1 Injectable Implant Urinary Incontinence Device Sales Channels

7.4.2 Injectable Implant Urinary Incontinence Device Distributors

7.5 Injectable Implant Urinary Incontinence Device Customer Analysis

8 Injectable Implant Urinary Incontinence Device Market Dynamics

8.1 Injectable Implant Urinary Incontinence Device Industry Trends

8.2 Injectable Implant Urinary Incontinence Device Market Drivers

8.3 Injectable Implant Urinary Incontinence Device Market Challenges

8.4 Injectable Implant Urinary Incontinence Device Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Injectable Implant Urinary Incontinence Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Injectable Implant Urinary Incontinence Device Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Injectable Implant Urinary Incontinence Device Market Competitive Situation by Manufacturers in 2024

Table 4. Global Injectable Implant Urinary Incontinence Device Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Injectable Implant Urinary Incontinence Device Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Injectable Implant Urinary Incontinence Device Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Injectable Implant Urinary Incontinence Device Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Injectable Implant Urinary Incontinence Device Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Injectable Implant Urinary Incontinence Device, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Injectable Implant Urinary Incontinence Device, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Injectable Implant Urinary Incontinence Device, Product Type & Application

Table 12. Global Key Manufacturers of Injectable Implant Urinary Incontinence Device, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Injectable Implant Urinary Incontinence Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Implant Urinary Incontinence Device as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Injectable Implant Urinary Incontinence Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Injectable Implant Urinary Incontinence Device Sales by Region (2020-2025) & (K Units)

Table 18. Global Injectable Implant Urinary Incontinence Device Sales Market Share by Region (2020-2025)

Table 19. Global Injectable Implant Urinary Incontinence Device Sales by Region (2026-2031) & (K Units)

Table 20. Global Injectable Implant Urinary Incontinence Device Sales Market Share by Region (2026-2031)

Table 21. Global Injectable Implant Urinary Incontinence Device Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Injectable Implant Urinary Incontinence Device Revenue Market Share by Region (2020-2025)

Table 23. Global Injectable Implant Urinary Incontinence Device Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Injectable Implant Urinary Incontinence Device Revenue Market Share by Region (2026-2031)

Table 25. North America Injectable Implant Urinary Incontinence Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Injectable Implant Urinary Incontinence Device Sales by Country (2020-2025) & (K Units)

Table 27. North America Injectable Implant Urinary Incontinence Device Sales by Country (2026-2031) & (K Units)

Table 28. North America Injectable Implant Urinary Incontinence Device Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Injectable Implant Urinary Incontinence Device Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Injectable Implant Urinary Incontinence Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Injectable Implant Urinary Incontinence Device Sales by Country (2020-2025) & (K Units)

Table 32. Europe Injectable Implant Urinary Incontinence Device Sales by Country (2026-2031) & (K Units)

Table 33. Europe Injectable Implant Urinary Incontinence Device Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Injectable Implant Urinary Incontinence Device Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Injectable Implant Urinary Incontinence Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Injectable Implant Urinary Incontinence Device Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Injectable Implant Urinary Incontinence Device Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Injectable Implant Urinary Incontinence Device Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Injectable Implant Urinary Incontinence Device Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Injectable Implant Urinary Incontinence Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Injectable Implant Urinary Incontinence Device Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Injectable Implant Urinary Incontinence Device Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Injectable Implant Urinary Incontinence Device Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Injectable Implant Urinary Incontinence Device Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Injectable Implant Urinary Incontinence Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Injectable Implant Urinary Incontinence Device Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Injectable Implant Urinary Incontinence Device Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Injectable Implant Urinary Incontinence Device Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Injectable Implant Urinary Incontinence Device Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Injectable Implant Urinary Incontinence Device Sales (K Units) by Type (2020-2025)

Table 51. Global Injectable Implant Urinary Incontinence Device Sales (K Units) by Type (2026-2031)

Table 52. Global Injectable Implant Urinary Incontinence Device Sales Market Share by Type (2020-2025)

Table 53. Global Injectable Implant Urinary Incontinence Device Sales Market Share by Type (2026-2031)

Table 54. Global Injectable Implant Urinary Incontinence Device Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Injectable Implant Urinary Incontinence Device Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Injectable Implant Urinary Incontinence Device Revenue Market Share by Type (2020-2025)

Table 57. Global Injectable Implant Urinary Incontinence Device Revenue Market Share by Type (2026-2031)

Table 58. Global Injectable Implant Urinary Incontinence Device Price (US$/Unit) by Type (2020-2025)

Table 59. Global Injectable Implant Urinary Incontinence Device Price (US$/Unit) by Type (2026-2031)

Table 60. Global Injectable Implant Urinary Incontinence Device Sales (K Units) by Application (2020-2025)

Table 61. Global Injectable Implant Urinary Incontinence Device Sales (K Units) by Application (2026-2031)

Table 62. Global Injectable Implant Urinary Incontinence Device Sales Market Share by Application (2020-2025)

Table 63. Global Injectable Implant Urinary Incontinence Device Sales Market Share by Application (2026-2031)

Table 64. Global Injectable Implant Urinary Incontinence Device Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Injectable Implant Urinary Incontinence Device Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Injectable Implant Urinary Incontinence Device Revenue Market Share by Application (2020-2025)

Table 67. Global Injectable Implant Urinary Incontinence Device Revenue Market Share by Application (2026-2031)

Table 68. Global Injectable Implant Urinary Incontinence Device Price (US$/Unit) by Application (2020-2025)

Table 69. Global Injectable Implant Urinary Incontinence Device Price (US$/Unit) by Application (2026-2031)

Table 70. Boston Scientific Company Information

Table 71. Boston Scientific Description and Business Overview

Table 72. Boston Scientific Injectable Implant Urinary Incontinence Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Boston Scientific Injectable Implant Urinary Incontinence Device Product

Table 74. Boston Scientific Recent Developments/Updates

Table 75. Laborie Medical Company Information

Table 76. Laborie Medical Description and Business Overview

Table 77. Laborie Medical Injectable Implant Urinary Incontinence Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Laborie Medical Injectable Implant Urinary Incontinence Device Product

Table 79. Laborie Medical Recent Developments/Updates

Table 80. Urogyn B.V. Company Information

Table 81. Urogyn B.V. Description and Business Overview

Table 82. Urogyn B.V. Injectable Implant Urinary Incontinence Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Urogyn B.V. Injectable Implant Urinary Incontinence Device Product

Table 84. Urogyn B.V. Recent Developments/Updates

Table 85. Key Raw Materials Lists

Table 86. Raw Materials Key Suppliers Lists

Table 87. Injectable Implant Urinary Incontinence Device Distributors List

Table 88. Injectable Implant Urinary Incontinence Device Customers List

Table 89. Injectable Implant Urinary Incontinence Device Market Trends

Table 90. Injectable Implant Urinary Incontinence Device Market Drivers

Table 91. Injectable Implant Urinary Incontinence Device Market Challenges

Table 92. Injectable Implant Urinary Incontinence Device Market Restraints

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

Table 96. Authors List of This Report

List of Figures

Figure 1. Product Picture of Injectable Implant Urinary Incontinence Device

Figure 2. Global Injectable Implant Urinary Incontinence Device Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Injectable Implant Urinary Incontinence Device Market Share by Type: 2024 & 2031

Figure 4. Stress Incontinence Product Picture

Figure 5. Urge Incontinence Product Picture

Figure 6. Overflow Incontinence Product Picture

Figure 7. Functional Incontinence Product Picture

Figure 8. Others Product Picture

Figure 9. Global Injectable Implant Urinary Incontinence Device Market Value by Application (2020-2031) & (US$ Million)

Figure 10. Global Injectable Implant Urinary Incontinence Device Market Share by Application: 2024 & 2031

Figure 11. Hospitals and Clinics

Figure 12. Ambulatory Surgery Centres

Figure 13. Others

Figure 14. Global Injectable Implant Urinary Incontinence Device Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Injectable Implant Urinary Incontinence Device Market Size (2020-2031) & (US$ Million)

Figure 16. Global Injectable Implant Urinary Incontinence Device Sales (2020-2031) & (K Units)

Figure 17. Global Injectable Implant Urinary Incontinence Device Average Price (US$/Unit) & (2020-2031)

Figure 18. Injectable Implant Urinary Incontinence Device Report Years Considered

Figure 19. Injectable Implant Urinary Incontinence Device Sales Share by Manufacturers in 2024

Figure 20. Global Injectable Implant Urinary Incontinence Device Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Injectable Implant Urinary Incontinence Device Players: Market Share by Revenue in Injectable Implant Urinary Incontinence Device in 2024

Figure 22. Injectable Implant Urinary Incontinence Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Injectable Implant Urinary Incontinence Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Injectable Implant Urinary Incontinence Device Sales Market Share by Country (2020-2031)

Figure 25. North America Injectable Implant Urinary Incontinence Device Revenue Market Share by Country (2020-2031)

Figure 26. U.S. Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Injectable Implant Urinary Incontinence Device Sales Market Share by Country (2020-2031)

Figure 29. Europe Injectable Implant Urinary Incontinence Device Revenue Market Share by Country (2020-2031)

Figure 30. Germany Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Injectable Implant Urinary Incontinence Device Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Injectable Implant Urinary Incontinence Device Revenue Market Share by Region (2020-2031)

Figure 37. China Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Taiwan Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Indonesia Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Thailand Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Malaysia Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Philippines Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Latin America Injectable Implant Urinary Incontinence Device Sales Market Share by Country (2020-2031)

Figure 48. Latin America Injectable Implant Urinary Incontinence Device Revenue Market Share by Country (2020-2031)

Figure 49. Mexico Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Brazil Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Argentina Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Middle East and Africa Injectable Implant Urinary Incontinence Device Sales Market Share by Country (2020-2031)

Figure 53. Middle East and Africa Injectable Implant Urinary Incontinence Device Revenue Market Share by Country (2020-2031)

Figure 54. Turkey Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. U.A.E Injectable Implant Urinary Incontinence Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Global Sales Market Share of Injectable Implant Urinary Incontinence Device by Type (2020-2031)

Figure 58. Global Revenue Market Share of Injectable Implant Urinary Incontinence Device by Type (2020-2031)

Figure 59. Global Injectable Implant Urinary Incontinence Device Price (US$/Unit) by Type (2020-2031)

Figure 60. Global Sales Market Share of Injectable Implant Urinary Incontinence Device by Application (2020-2031)

Figure 61. Global Revenue Market Share of Injectable Implant Urinary Incontinence Device by Application (2020-2031)

Figure 62. Global Injectable Implant Urinary Incontinence Device Price (US$/Unit) by Application (2020-2031)

Figure 63. Injectable Implant Urinary Incontinence Device Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Injectable Implant Urinary Incontinence Device market? zhanKai

The top companies in the global Injectable Implant Urinary Incontinence Device market are Boston Scientific、Laborie Medical、Urogyn B.V..

What was the global market size of Injectable Implant Urinary Incontinence Device in 2031? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Injectable Implant Urinary Incontinence Device in 2025? shouQi

What is the annual compound growth rate of the global Injectable Implant Urinary Incontinence Device market size from 2025 to 2031? shouQi

Related Reports

Injectable Implant Urinary Incontinence Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Injectable Implant Urinary Incontinence Device was estimated to be worth US$ 131 million in 2025 and is projected to reach US$ 194 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 121
USD 3950.00
(Single User License)
Global Injectable Implant Urinary Incontinence Device Market Research Report 2026
The global Injectable Implant Urinary Incontinence Device market was valued at US$ 131 million in 2025 and is anticipated to reach US$ 194 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 104
USD 2900.00
(Single User License)
Global Injectable Implant Urinary Incontinence Device Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Injectable Implant Urinary Incontinence Device market size was US$ 124 million in 2024 and is forecast to a readjusted size of US$ 185 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 67
USD 4250.00
(Single User License)
Global Injectable Implant Urinary Incontinence Device Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Injectable Implant Urinary Incontinence Device market is projected to grow from US$ 124 million in 2024 to US$ 185 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 118
USD 4900.00
(Single User License)
Injectable Implant Urinary Incontinence Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Injectable Implant Urinary Incontinence Device was estimated to be worth US$ 124 million in 2024 and is forecast to a readjusted size of US$ 185 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 82
USD 3950.00
(Single User License)
Global Injectable Implant Urinary Incontinence Device Market Insights, Forecast to 2030
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published Date: 2024-04-12
Pages: 75
USD 4900.00
(Single User License)
Global Injectable Implant Urinary Incontinence Device Market Research Report 2024
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published Date: 2024-01-17
Pages: 74
USD 2900.00
(Single User License)
Injectable Implant Urinary Incontinence Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published Date: 2024-01-10
Pages: 82
USD 3950.00
(Single User License)

Injectable Implant Urinary Incontinence Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Injectable Implant Urinary Incontinence Device was estimated to be worth US$ 131 million in 2025 and is projected to reach US$ 194 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-06-16
Pages: 121
USD 3950.00 (Single User License)
Global Injectable Implant Urinary Incontinence Device Market Research Report 2026
The global Injectable Implant Urinary Incontinence Device market was valued at US$ 131 million in 2025 and is anticipated to reach US$ 194 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-04-17
Pages: 104
USD 2900.00 (Single User License)
Global Injectable Implant Urinary Incontinence Device Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Injectable Implant Urinary Incontinence Device market size was US$ 124 million in 2024 and is forecast to a readjusted size of US$ 185 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 67
USD 4250.00 (Single User License)
Global Injectable Implant Urinary Incontinence Device Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Injectable Implant Urinary Incontinence Device market is projected to grow from US$ 124 million in 2024 to US$ 185 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 118
USD 4900.00 (Single User License)
Injectable Implant Urinary Incontinence Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Injectable Implant Urinary Incontinence Device was estimated to be worth US$ 124 million in 2024 and is forecast to a readjusted size of US$ 185 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 82
USD 3950.00 (Single User License)
Global Injectable Implant Urinary Incontinence Device Market Insights, Forecast to 2030
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published: 2024-04-12
Pages: 75
USD 4900.00 (Single User License)
Global Injectable Implant Urinary Incontinence Device Market Research Report 2024
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published: 2024-01-17
Pages: 74
USD 2900.00 (Single User License)
Injectable Implant Urinary Incontinence Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published: 2024-01-10
Pages: 82
USD 3950.00 (Single User License)